Pacira reported $148.16M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Astellas Pharma JPY 297.26B 9.92B Mar/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Ironwood Pharmaceuticals USD 0 0 Dec/2020
J&J USD 12.66B 215M Mar/2025
Ligand Pharmaceuticals USD 15.49M 875K Jun/2025
Novo Nordisk 45.65B 21.26B Jun/2025
Pacira USD 148.16M 14.41M Jun/2025
Perrigo USD 1.22B 60.5M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
Supernus Pharmaceuticals USD 44.02M 5.4M Jun/2025
Teva Pharmaceutical Industries USD 3.5B 250M Jun/2025
Xeris Pharmaceuticals USD 67.28M 14.59M Jun/2025
Zoetis USD 2.44B 74M Jun/2025